News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
The health secretary has used peer pressure to persuade food makers to nix synthetic dyes. The candy industry is holding out, ...
MONDAY, July 7, 2025 — Two babies in Oregon got sick with lead poisoning after eating baby food from Target that was ...
Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.
7hon MSN
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
In addition to finding these dyes in brightly colored processed foods, the researchers also found them in more muted foods ...
The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
9h
Grist on MSNHow to access food before, during, and after a disasterStore items in a cool, dry place away from direct sunlight. Place your food supply on high shelves to keep them far from any ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results